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Abstract
Objective: Empyema thoracic is known to have a variable age group affection, causative agents and controversy regarding primary 
mode of management. The aim of this study was to study the epidemiology, management strategies including investigations and outcome 
of empyema in the children. Methods: A prospective study was done on all cases of parapneumonic empyema admitted to our hospital 
from February 2009 to April 2011. Diagnosis of empyema was confirmed by chest X-ray, pleural fluid analysis or radio-imaging. All 
children (depending on staging) were treated along with parental antibiotics and chest tube drainage either intrapleural urokinase or 
surgery (video assisted thoracoscopy surgery [VATS] or thoracotomy) according to British Thoracic Society guidelines. Results: Among 
study population, male to female ratio was 1.48:1. The most common age group affected was 1-5 years (mean 4.03 ± 3.30 years). Total 
31.57% of the cultures were positive. The most common isolated organisms were Streptococci (38.9%) and Staphylococci (44.4%). 
Out of 57 children, 25 had Stage II of empyema while 32 had Stage III of empyema. There was a significant correlation between 
duration of illness (>7 days) and advancement in the stage of empyema (p < 0.0001). Only one child with Stage II of empyema 
required surgery while remaining all other (24 out of 25) were managed with thoracostomy and intrapleural injection of urokinase. 
Remaining 32 (18 VATS and 14 thoracotomy) patients with Stage III of empyema underwent primary surgical management. There was 
no significant difference in the duration of fever remission, total hospital stay or duration of IV antibiotics in children treated either 
with intrapleural fibrinolytics or surgical management. Overall outcome of empyema was excellent, mortality was less than 1.5%, with 
overwhelming sepsis. Conclusion: Staging of empyema at initiation of treatment helps in proper management of patients. Results with 
the use of intrapleural fibrinolytics were promising in the Stage II of empyema. As complications are very few, VATS is a safe procedure 
in experienced hands.
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Empyema is a localized or free collection of purulent material in the pleural space formed as a result of a combination of pleural dead space, culture medium of 
pleural fluid and inoculation of the bacteria [1]. The cultures 
are sterile in 30-50% of the cases due to antibiotics [2-4]. 
Staphylococcus aureus is now the most commonly retrieved 
organism with increasing incidence of methicillin-resistant 
S. aureus (MRSA) [5]. It is an advanced parapneumonic 
effusion. While most cases would respond to antibiotic therapy, 
needle aspiration, fibrinolytics and intercostal drainage (ICD), 
few cases require further surgical management. There is general 
agreement that patients with empyema require a drainage 
procedure. However, differing definitions of “empyema” and 
differing opinions about the appropriate drainage procedure 
have contributed to the ongoing controversy about the 
management of these patients. In this study, we have followed 
British Thoracic Society (BTS) guidelines [6] for the diagnosis 
and management of empyema patients. We conducted 
observational perspective study to determine epidemiology, 
management strategies including investigations and outcome 
of empyema in the children.
METHODS
This study was done in a tertiary care referral pediatric hospital 
in Hyderabad between February 2009 and April 2011. All the 
children between 2 months and 18 years of age admitted to 
our hospital either directly or referred from another hospital 
with clinical signs suggestive of pneumonia were included 
in the study. Diagnosis of empyema was confirmed by chest 
X-ray, pleural fluid analysis or radio-imaging according to 
BTS guidelines. Those who have bronchopneumonia with 
just synpneumonic effusion, empyema thoracic secondary to 
trauma or surgery were excluded.
At the time of admission, detailed history was taken, 
and clinical examination was performed. Investigations 
like complete blood count, erythrocyte sedimentation rate, 
C-reactive protein, blood culture, Mantoux test, sputum for 
acid-fast bacilli (AFB) (if available) and chest X-ray were 
done. Pleural fluid was collected at the time of insertion of 
chest tube. Fluid was subjected to cell count, protein, sugar, 
AFB and Gram-stain and culture. In cases where dry tap was 
Vol 2 | Issue 1 | Jan - Mar 2015 Indian J Child Health 6
Shah et al. Empyema Profile in Children
present due to pleural peel or ultrasound suggestive of thick 
loculations, early surgical interventions were considered. 
Computed tomography (CT) scan chest was done whenever 
required. Patients who were referred from another hospital due 
to failure of primary treatment were reinvestigated and treated 
accordingly.
All the children were categorized into simple parapneumonic 
effusion (Stage I), complicated parapneumonic effusion 
(Stage II) or Organizational stage, (Stage III) [6,7]. Treatment 
protocol was followed according to BTS guidelines. Accordingly, 
patients with a preliminary diagnosis of Stage II of empyema 
were treated with intrapleural urokinase as a primary mode of 
treatment. Injection Urokinase was given twice daily for 3 days 
(total 6 doses) in a dose of 40,000 units in 40 ml normal saline 
(in children > 1 year or 10 kg) or 10,000 units in 10 ml normal 
saline (in children <1 year or 10 kg) with 4 h of indwelling time. 
After 3 had completed days of fibrinolytics, repeat chest X-ray 
was done to see the signs of resolution of collection. Antibiotics 
were continued until the patient is afebrile, white blood cell 
(WBC) count is normal, daily tube thoracostomy yield is <50 ml 
and radiograph shows considerable clearing.
Baseline characteristics for all the children with empyema 
treated with only antibiotics, intercostal tube drainage with 
fibrinolytics or surgical management were compared with 
each other using Chi-square test or fisher extract test. The 
significance level for all the tests is set at p < 0.05. Follow-up 
of all patients was done after 1 month to check for clinical and 
radiological clearance.
RESULTS
Out of 57 cases studied, majority (57%) were in the age group 
of 1-5 years (mean age 4.03 ± 3.30 years). Males (61%) were 
more affected than females. Both sites of the lung were involved 
equally while 2 cases had bilateral involvement. Incidence of 
disease is maximum in February (20%) and more in children 
with malnutrition (42%).
Most common presenting complaints were cough (98.00%), 
fever (96.48%), breathlessness (61.40%) and chest pain 
(10.52%). Duration of fever before presentation was one week 
in 35.71% of patients, 1-2 weeks in 47.21% of patients and 
more than 2 weeks for 16.08% of the patients. Out of 30 patients 
having long duration (more than 7 days) of illness, 25 (80%) 
were found to have Stage III of empyema. Out of 27 patients 
having short duration (<7 days) of illness, 20 (74%) were found 
to have Stage II of empyema. Duration of illness (>7 days) 
was very significantly related to advancement in the stage of 
empyema (p < 0.0001).
On pleural fluid culture, gram stainable organism was found 
in only 18 (31.58%) patients. Totally, 16 out of 18 had Gram-
positive (88.89%) bacilli, while Gram-negative (11.11%) 
organism was rarely found (2 out of 18). In only 18 (31.57%) 
cases, cultures were positive. Out of these, 38.9 % of the 
cultures grown streptococci while staphylococci were seen in 
44.4% cases. Three of the patients had isolated Acinetobacter, 
Enterococci or Enterobacter species, all of them were treated 
at referral hospital with interventional management i.e. ICD. 
In this study, bacterial culture sensitivity report by BACTEC 
technique showed that all streptococci are sensitive to third-
generation cephalosporins and respiratory fluoroquinolones. 
These were moderately sensitive to penicillin and macrolides. 
Staphylococci organisms were ampicillin and penicillin 
resistant. There is moderate sensitivity toward third-generation 
cephalosporins. Out of 8 positive cultures, 1 had MRSA positive 
which was community acquired.
A total of 25 patients were treated with ICD and intrapleural 
urokinase as the primary mode of management. After 
completion of the treatment, one had persistent necrotizing 
right upper lobe consolidation (necrotizing pneumonia) that 
required thoracotomy with upper lobectomy. Totally, 20 
children required primary decortication without trying chest 
tube in view of negative or minimal aspirate, but radiological 
investigation revealed solidified pleural material with 
significant compression of the lung. Remaining 12 children 
had failure of primary treatment (ICD + IV antibiotics) required 
surgical management either video assisted thoracoscopy 
surgery (VATS) or thoracotomy (Figs. 1 and 2).
Antibiotic was continued until the patient is afebrile, WBC 
count is normal, tube thoracostomy yield is <50 ml of fluid 
per day and radiograph shows considerable clearing. We 
found no significant difference between patients managed 
with fibrinolytics or surgically with respect to fever remission 
time in the hospital, duration of hospitalization and duration of 
IV  antibiotics.
Mean duration of hospital stay was found 12 days. 
Surgically treated children required significantly (p = 0.0067) 
shorter duration of oral antibiotics as compared to fibrinolytics 
Duration in days Medically managed Surgically managed Student 
t-testChest tube drain (n=25) VATs (n=18) Thoracotomy (n=14)
Fever remission time in hospital 4.52±3.016 4.22±2.73 5.5±3.27 p=0.234
Duration of hospitalization 11.64±4.06 12.05±4.37 11.64±3.94 p=0.837
Duration of IV antibiotics 12.44±4.24 12.38±4.52 11.85±5.27 p=0.735
Duration of oral antibiotics 8.2±5.50 4.16±2.74 5.85±4.47 p=0.0067
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group. Out of 57 patients, 1 child died due to Acinetobacter 
sepsis. Overall outcome of empyema is excellent, and mortality 
was 1.5% due to overwhelming sepsis.
DISCUSSION
This study reports similar epidemiological profile including 
age group, sex, nutritional status, seasonal variation and 
clinical presentation of the disease as noted by other studies in 
same geographical area [1,3,8-11]. Duration of the illness and 
stage of the disease are significantly correlated. We observed 
that more than 60% of the children who were referred from 
other hospitals had organized stage of the empyema requiring 
surgery. All children who presented with more than 7 days 
of illness and partially treated with only antibiotics found to 
have advanced stage of disease. Timely institution of proper 
management prevents the need for any surgical intervention 
and avoids long-term morbid complications.
Although pleural fluid is often sterile due to prior 
administration of antibiotics, it must be sent for culture. In our 
study, 31.57% cultures were positive with streptococci and 
staphylococci being the common organisms. Culture of the one 
child grown MRSA that was community acquired. Similar results 
are seen in previous studies that showed that cultures were sterile 
in 30-50% of the cases due to prior antibiotics exposure and 
S. aureus was the most commonly retrieved organism [12-14]. 
The increasing incidence of methicillin-resistant staphylococci 
has been reported [5,15]. In this study, bacterial culture sensitivity 
report by BACTEC technique showed that all streptococci are 
sensitive to third-generation cephalosporins and respiratory 
fluoroquinolones. Parenteral therapy should be continued for 
48-72 h after abatement of fever, and then oral therapy can be 
used to complete the course [9].
We found that all the patients had evidence of fluid on X-ray 
while 15 children on X-ray had presented with “white out” 
lungs. In children with Stage II of empyema showed hypoechoic 
lesion with thin septations. In this study, 20 children were 
managed with early surgical intervention, who showed thicken 
pleura with multiple internal echoes on ultrasound. In all of 
them thickness of pleura was >2.5 mm and later on found to 
have Stage III (organizational stage) of empyema. Sonography 
can distinguish solid from liquid pleural abnormalities with 
92% accuracy compared to 68% accuracy with chest X-ray, 
when results of both are combined, accuracy rises to 98% [16].
Out of 57 children, CT scan was done in 37 children, and 
only 8 scans showed positive “split sign” (thick pleural peel). 
In remaining patients, CT failed to provide any addition 
information as compared to USG. All features on CT are 
being highly suggestive but non-specific for empyema rather 
than sterile pleural effusion [17-19]. Considering the risk of 
radiation exposure and need of intravenous contrast, use of CT 
scan to diagnose empyema is not advocated.
In our study, only one child with Stage II of empyema 
required surgery while remaining all other (24 out of 25) 
were managed with thoracostomy and intrapleural injection 
of Urokinase. Similar results occurred in 118 patients with 
complicated pleural fluid collections studied by Moulton 
et  al. [20] full clinical recovery in 111 patients (94%). Bouros 
et al. [21] evaluated low-dose Urokinase in 20 patients with 
pleural effusion and empyema and showed the success of 
low-dose Urokinase, and the low cost is comparable to that of 
streptokinase without any significant complications.
There are no evidence-based criteria to guide the decision 
on when a child should proceed to surgery [6]. Early use of 
VATS enhances the chance of full expansion of the collapsed 
lung, and drainage of the empyema fluid is significantly 
improved when performed under direct vision [22-24]. We 
found no significant difference between patients managed 
only with chest drain or surgical management. In a study done 
by Satpathy et al. [10], mean duration of hospital stay was 
12 days and fever remission time was significantly less in chest 
drain group. In our study, surgically treated children required 
Figure 1: Multiple thick loculated slough in the pleural 
cavity
Figure 2: Pleural peal being removed thoracoscopically
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significantly (p = 0.0067) shorter duration of antibiotics as 
compared to chest drain group. Similar results were seen in the 
study by Satpathy et al. [10], where combined duration of IV 
and oral antibiotics was lesser in the thoracotomy group.
CONCLUSION
To conclude, our observation suggests that results with the 
use of intrapleural fibrinolytics are promising in Stage II 
of empyema. As complications are very few, VATS is a safe 
procedure in experienced hands. Where fibrinolytics or VATS 
are not freely available or feasible, decortication remains a 
valuable and indispensable tool.
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